Insulin Patch Pump Market Size Is Expected To Witness Significant Growth By 2025

Publish Date : 2017-08-01

A research study titled, “Insulin Patch Pump Market by Type and Application - Global Industry Analysis and Forecast to 2025” published by Crystal Market Research, states that Insulin Patch Pump Market is expected to witness significant growth by 2025.

Diabetes is a chronic disease which occurs either when the pancreas fails to develop sufficient insulin or when the human body is unable to effectively use the insulin. Symptoms associated with diabetes are frequent urination, blurred vision, increased thirst, rapid weight loss, numbness or tingling sensation in hands or feet and increased hunger. Factors which escalate the risk of diabetes are family history, ethnicity, physical inactivity,unhealthy diet, and smoking. Diabetes can damage the heart, eyes, blood vessels, kidneys, and nerves which may lead to disability and premature death. There are three types of diabetes, namely, type 1, type 2, and gestational diabetes. Type 1 diabetes can cause because of complex interaction between genes and environmental factors. The most common risk factors for type 2 diabetes are overweight and obesity. Type 2 diabetes is the most common type of diabetes worldwide. It is typically countered with changes in lifestyle activities such as improved diet and increased physical activity. While insulin is rarely prescribed as the initial drug for a type 2 diabetes patient, many of them may ultimately need it to control blood glucose levels. Insulin patch pumps may work very well for numerous patients suffering from type 2 diabetes.

The development of patch pump technology has given an opportunity for improving the quality of life of a broad demography of diabetes patients. The insulin patch pump technology offers enhanced therapeutic benefits over traditional multiple daily injection therapy. Currently available patch pumps are about the size of a computer mouse which can be directly attached to the body without any tubing. For the infusion of insulin, a small catheter is subcutaneously inserted from the underside of the patch pump. The three main components of an insulin patch pump are an insulin reservoir, a cannula and a pumping mechanism. Unlike traditional pumps, these parts are contained in a single case without any tubing. The device is directly worn on the body using an adhesive patch. The activation of the patch is programmed from a remote device and the cannula is inserted automatically.

Basal insulin comprises of a majority of a person’s daily insulin requirement. It offsets the liver’s glucose secretion into the bloodstream. Every few minutes, the pancreas, in response to the liver’s secretion of glucose, secretes a small amount of insulin in the bloodstream which is known as basal insulin. Before a person develops diabetes, pancreas regularly produce insulin proportionate to the amount of glucose present in the bloodstream.When there is a large amount of blood glucose in the body, such as after meals, the pancreas secret larger amounts of insulin known as bolus insulin.Using patch pumps, the rate of insulin delivery can be adjusted in response to the liver’s pattern of glucose secretion.

The major factor responsible for the growth of insulin pump market is increasing prevalence of diabetes. According to IDF, in 2015, diabetes affected 415 million people worldwide. This number is expected to reach up to 642 million by 2040.By 2040, 1 in 10 adults will have diabetes. With such rising incidence of diabetes around the world, the demand for insulin patch pumps is expected to increase favorably during the forecast period. As diabetic patients are becoming increasingly aware about the technologically advanced alternatives to control and manage diabetes, the insulin patch pump marketwill experience innovationsin the near future leading to development of new-age insulin patch pump systems with enhanced insulin delivering capabilities.

Some of the major players operating in the insulin patch pump marketare, Insulet Corporation, Debiotech S.A.,CeQur SA,Unilife Corporation,Valeritas Holdings, Inc., Cellnovo Limited., EOFLOW CO., LTD., Becton, Dickinson and Company.

Browse full research report with TOC on “Insulin Patch Pump Market by Type of Insulin and End User - Global Industry Analysis and Forecast to 2025” at:

https://www.crystalmarketresearch.com/report/insulin-patch-pump-market

Key Findings of the Research Study:

  • Rising incidence of diabetes around the world is expected to primarily drive the growth of insulin patch pump market during the forecast period.
  • Insulin patch pump provides an efficient alternative to traditional multiple injection based insulin delivery systems.
  • Development of insulin patch pumps by numerous players under pipeline will favorably contribute to the market growth over coming few years.
  • North America holds the major share of the insulin patch pump market due to the commercial availability and rapid adoption of insulin patch pumps in the region.

Insulin Patch Pump Market Segmentation:

By Type of Insulin:

  • Basal Insulin
  • Bolus Insulin
  • Basal-Bolus Insulin

By End User:

  • Hospitals
  • Private clinics
  • Online pharmacies
  • Retail pharmacies

By Region:

  • North America
  • U.S
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest of Asia Pacific
  • Rest of the World
  • Brazil
  • South Africa
  • Saudi Arabia
  • United Arab Emirates
  • Others

Related Reports